Jatinder Singh

Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide Phosphoribosyltransferase

Tanja S. Zabka, Jatinder Singh, Preeti Dhawan et al. · Toxicological Sciences · 2014 · 83 citations · Full text

Ocular Disease, Optogenetics, Oxidative Stress +16

A Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib in Combination with the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors

Colin D. Weekes, A. Craig Lockhart, Patricia LoRusso et al. · The Oncologist · 2020 · 52 citations · Full text

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry

Brendan D. Curti, Gregory A. Daniels, David F. McDermott et al. · Journal for ImmunoTherapy of Cancer · 2017 · 38 citations · Full text

Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid

Jacqueline M. Tarrant, Preeti Dhawan, Jatinder Singh et al. · Toxicology Mechanisms and Methods · 2015 · 30 citations

Chemoprevention Strategy, Nicotinamide Adenine Dinucleotide, Pharmacotherapy +21

Reversal of Tamoxifen Resistance (Hormone Resistance) by Addition of Sirolimus (mTOR Inhibitor) in Metastatic Breast Cancer

G.S. Bhattacharvva, Jaya Biswas, Jatinder Singh et al. · European Journal of Cancer · 2011 · 27 citations

Metastatic Breast Cancer, Breast Oncology, Tamoxifen Resistance +9